Inreda artificial pancreas device for Type 1 diabetes
NIHR HSRIC
Record ID 32016000454
English
Authors' objectives:
The Inreda system is a bi-hormonal artificial pancreas device that has been developed by Inreda Diabetic for the treatment of patients with insulin dependent Type 1 diabetes. The company state the device is intended for continuous use at home to provide automatic administration of both insulin and glucagon, when needed.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.hsric.nihr.ac.uk/topics/inreda-artificial-pancreas-device-for-type-1-diabetes/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- Diabetes Mellitus, Type 1
- Insulin Infusion Systems
- Pancreas, Artificial
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.